Gary Pasternack, Baltimore US
Gary Pasternack, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20080299641 | Novel E. coli 0157:H7 bacteriophage and uses thereof - The present invention is directed to isolated bacteriophage having strong lytic activity against strains of | 12-04-2008 |
20080311643 | Novel Pseudomonas aeruginosa: Bacteriophage and Uses Thereof - The present invention is directed to isolated bacteriophage having strong lytic activity against strains of | 12-18-2008 |
20090047726 | Novel Clostridium perfringens Bacteriophage and Uses Thereof - The present invention is directed to isolated bacteriophage having strong lytic activity against strains of | 02-19-2009 |
20090047727 | Novel Clostridium perfringens Bacteriophage and Uses Thereof - The present invention is directed to isolated bacteriophage having strong lytic activity against strains of | 02-19-2009 |
20090155217 | Novel E. coli O157:H7 Bacteriophage and Uses Thereof - The present invention is directed to isolated bacteriophage having strong lytic activity against strains of | 06-18-2009 |
20090155329 | Novel E. coli Bacteriophage and Uses Thereof - The present invention is directed to isolated | 06-18-2009 |
20100068787 | Novel Staphylococcus aureus: Bacteriophage and Uses Thereof - The present invention is directed to isolated bacteriophage having strong lytic activity against strains of | 03-18-2010 |
20130336932 | Novel Salmonella Bacteriophage and Uses Thereof - The present invention is directed to isolated bacteriophages having specificity and lytic activity against strains of | 12-19-2013 |